Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

Press Releases

Bone Therapeutics and Cellthera Pharm LLC announce intention to collaborate and Bone Therapeutics provides overview of its pipeline

  • Read more about Bone Therapeutics and Cellthera Pharm LLC announce intention to collaborate and Bone Therapeutics provides overview of its pipeline

Bone Therapeutics Launches Equity Placement

  • Read more about Bone Therapeutics Launches Equity Placement

Bone Therapeutics Provides Update on Equity Placement

  • Read more about Bone Therapeutics Provides Update on Equity Placement

Bone Therapeutics réaffirme son éligibilité au PEA-PME pour 2018

  • Read more about Bone Therapeutics réaffirme son éligibilité au PEA-PME pour 2018

Bone Therapeutics provides business outlook and announces its financial calendar for 2018

  • Read more about Bone Therapeutics provides business outlook and announces its financial calendar for 2018

Bone Therapeutics completes patient recruitment for Phase IIA Spinal Fusion study with ALLOB

  • Read more about Bone Therapeutics completes patient recruitment for Phase IIA Spinal Fusion study with ALLOB

Bone Therapeutics strengthens Board with the appointment of Jean Stéphenne as Chairman

  • Read more about Bone Therapeutics strengthens Board with the appointment of Jean Stéphenne as Chairman

Bone Therapeutics Announces Private Placement of Convertible Bonds

  • Read more about Bone Therapeutics Announces Private Placement of Convertible Bonds

Bone Therapeutics Successfully Raises EUR 19.45 Million of Commitments in Convertible Bond Placement

  • Read more about Bone Therapeutics Successfully Raises EUR 19.45 Million of Commitments in Convertible Bond Placement

Bone Therapeutics: Information on the total number of voting rights and shares

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares

Pagination

  • Previous page ‹‹
  • Next page ››
Subscribe to Press Releases
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions